Sharon X. Wen

Array ( [id] => 11277100 [patent_doc_number] => 09493576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 14/459787 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 163 [patent_no_of_words] => 73142 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954830 [patent_doc_number] => 20140357852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'NUCLEIC ACID ENCODING ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 14/459743 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 73089 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945827 [patent_doc_number] => 20140348849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Compounds and Method for Modulating Inflammatory Reactions' [patent_app_type] => utility [patent_app_number] => 14/458449 [patent_app_country] => US [patent_app_date] => 2014-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10268 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14458449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9970676 [patent_doc_number] => 09017678 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-04-28 [patent_title] => 'Method of treating rheumatoid arthritis using antibody to IL6R' [patent_app_type] => utility [patent_app_number] => 14/457536 [patent_app_country] => US [patent_app_date] => 2014-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 137723 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14457536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843649 [patent_doc_number] => 08945560 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-02-03 [patent_title] => 'Method of treating rheumatoid arthritis using antibody to IL6R' [patent_app_type] => utility [patent_app_number] => 14/457566 [patent_app_country] => US [patent_app_date] => 2014-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 137654 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14457566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822102 [patent_doc_number] => 20160168266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'MEDICAMENT COMPRISING ANTI-PHOSPHOLIPASE D4 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 14/908004 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15492 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10932005 [patent_doc_number] => 20140335023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'PLASMA KALLIKREIN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/339053 [patent_app_country] => US [patent_app_date] => 2014-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 78182 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14339053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933135 [patent_doc_number] => 20140336156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'ANTIBODIES TO 25-HYDROXYVITAMIN D2 AND D3 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/335686 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23585 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977053 [patent_doc_number] => 09023359 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-05-05 [patent_title] => 'Targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/331665 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 83988 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857306 [patent_doc_number] => 20150037323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'HUMANIZED AXL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/331709 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 78 [patent_no_of_words] => 47836 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10007873 [patent_doc_number] => 09051378 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-09 [patent_title] => 'Targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/331609 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 83998 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12227535 [patent_doc_number] => 09914769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-13 [patent_title] => 'Precision medicine for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/331730 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 87755 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10812164 [patent_doc_number] => 20160158325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'METHOD OF TREATING FIBROPROLIFERATIVE DISORDERS INCLUDING DUPUYTREN\'S DISEASE WITH ONE OR MORE SPECIFIC HUMAN MATRIX METALLOPROTEINASE AND A TNF ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 14/904391 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5716 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9792231 [patent_doc_number] => 20150004174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'METHODS FOR TREATING HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA' [patent_app_type] => utility [patent_app_number] => 14/316587 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 133 [patent_figures_cnt] => 133 [patent_no_of_words] => 77109 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14316587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785233 [patent_doc_number] => 20140302048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'PLASMA KALLIKREIN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/310814 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 89783 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14310814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10961340 [patent_doc_number] => 20140364371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS' [patent_app_type] => utility [patent_app_number] => 14/297531 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7949 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945761 [patent_doc_number] => 20140348782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS' [patent_app_type] => utility [patent_app_number] => 14/295598 [patent_app_country] => US [patent_app_date] => 2014-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12731 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945762 [patent_doc_number] => 20140348783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS' [patent_app_type] => utility [patent_app_number] => 14/295660 [patent_app_country] => US [patent_app_date] => 2014-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12734 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13194099 [patent_doc_number] => 10111953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-30 [patent_title] => Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) [patent_app_type] => utility [patent_app_number] => 14/290544 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14618 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953348 [patent_doc_number] => 20140356370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS' [patent_app_type] => utility [patent_app_number] => 14/290462 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18392 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290462 [rel_patent_id] =>[rel_patent_doc_number] =>)